Agile Vaccine Development Expertise

Accelerating vaccine development to prevent and treat virulent diseases

Vaccine developers worldwide are faced with the challenge of quickly and safely advancing their vaccines through clinical development and approval to prevent millions of deaths every year.   Infectious disease pandemics like Ebola, MERS and COVID-19 come to mind currently, requiring a rapid response to regional or global outbreaks. Equally important are vaccines to prevent or treat cancers, viral, and bacterial infections that impact the length or quality of human lives.  

Understanding Vaccine Trials

We understand that vaccine development has a unique set of challenges, so Veristat has assembled an extraordinary team of scientific-minded experts who have planned and executed over 140 vaccine clinical trials and supported numerous marketing applications.  

Whether a vaccine to prevent or treat cancer recurrence or progression, or rapidly responding to an infectious disease outbreak, like the ongoing COVID-19 pandemic, we solve the problems that arise in testing immunotherapy vaccines, live or inactivated viral vaccines or DNA vaccines.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     

Veristat_icon_vaccine

> 140

vaccine clinical trials supported


Veristat_icon_oncology-216-1

> 40

cancer vaccine clinical trials supported


Veristat_icon_data manager

> 8

marketing applications prepared for vaccines



Breadth of Vaccine Experience

Knowledge From a Broad Range of Vaccine Experience
  
Botulinum Vaccine
  
Lymphoma
  
Breast Cancer
  
Melanoma
  
C Difficile
  
Metastatic Breast Cancer
  
Cervical Cancer
  
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  
Colorectal Cancer
  
Non-Small Cell Lung Cancer
  
COVID-19
  
Pancreatic Cancer
  
Ebola
  
Pandemic Flu
  
Gastric Cancer
  
Prostate Cancer
  
Glioblastoma
  
Renal Cell Cancer
  
Head and Neck Squamous Cell Carcinoma (HNSCC)
  
Respiratory Syncytial Virus
  
Hepatitis A
  
Shingles -Varicella-Zoster Virus (VZV)
  
Hepatitis B
  
Smallpox
  
Herpes (HSV2)
  
Thyroid Cancer
  
Human Papilloma Virus (HPV)
  
Typhoid Fever
  
Influenza
  
Vulva Cancer
  
Liver Metastasis
  
Yellow Fever

 

Learn More with These Resources

Infographic
The Time for Virtual Clinical Trials is Now

Download the infographic to learn how virtual trials are defined, the tool kits required to run a virtual trial, examples of what the patient experience can look ...

Case Study
Rapid Launch of a Phase I COVID-19 Vaccine Trial

Learn how the Veristat team quickly mobilized to help a sponsor get their clinical trial databased designed and launched in two weeks in order to achieve ...

Fact Sheet
COVID-19 Success Guide

As you consider the impact that the COVID-19 pandemic has on your programs, there are some key strategies that could help you maintain momentum, assess your risks and ...

Request A Proposal